Quince Therapeutics, Inc.

Quince Therapeutics, Inc. financial statements

Quince Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 83.98MEODHD
Cash and equivalentsUSD 5.81MEODHD
Total debtUSD 18.47MEODHD

Quince Therapeutics, Inc. financials on 6ix · Quince Therapeutics, Inc. on 6ix